<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rivello F</submitter><funding>Radboud University Nijmegen</funding><funding>Gellderland Province</funding><pagination>eaaz3849</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7527228</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(40)</volume><pubmed_abstract>Despite their important role in metastatic disease, no general method to detect circulating stromal cells (CStCs) exists. Here, we present the Metabolic Assay-Chip (MA-Chip) as a label-free, droplet-based microfluidic approach allowing single-cell extracellular pH measurement for the detection and isolation of highly metabolically active cells (hm-cells) from the tumor microenvironment. Single-cell mRNA-sequencing analysis of the hm-cells from metastatic prostate cancer patients revealed that approximately 10% were canonical EpCAM&lt;sup>+&lt;/sup> hm-CTCs, 3% were EpCAM&lt;sup>-&lt;/sup> hm-CTCs with up-regulation of prostate-related genes, and 87% were hm-CStCs with profiles characteristic for cancer-associated fibroblasts, mesenchymal stem cells, and endothelial cells. Kaplan-Meier analysis shows t</pubmed_abstract><journal>Science advances</journal><pubmed_title>Probing single-cell metabolism reveals prognostic value of highly metabolically active circulating stromal cells in prostate cancer.</pubmed_title><pmcid>PMC7527228</pmcid><funding_grant_id>Radboud Nanomedicine Alliance</funding_grant_id><funding_grant_id>Proeftuin Nanomedicine</funding_grant_id><pubmed_authors>Mehra N</pubmed_authors><pubmed_authors>Smits M</pubmed_authors><pubmed_authors>Matula K</pubmed_authors><pubmed_authors>Huck WTS</pubmed_authors><pubmed_authors>Rivello F</pubmed_authors><pubmed_authors>Piruska A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Probing single-cell metabolism reveals prognostic value of highly metabolically active circulating stromal cells in prostate cancer.</name><description>Despite their important role in metastatic disease, no general method to detect circulating stromal cells (CStCs) exists. Here, we present the Metabolic Assay-Chip (MA-Chip) as a label-free, droplet-based microfluidic approach allowing single-cell extracellular pH measurement for the detection and isolation of highly metabolically active cells (hm-cells) from the tumor microenvironment. Single-cell mRNA-sequencing analysis of the hm-cells from metastatic prostate cancer patients revealed that approximately 10% were canonical EpCAM&lt;sup>+&lt;/sup> hm-CTCs, 3% were EpCAM&lt;sup>-&lt;/sup> hm-CTCs with up-regulation of prostate-related genes, and 87% were hm-CStCs with profiles characteristic for cancer-associated fibroblasts, mesenchymal stem cells, and endothelial cells. Kaplan-Meier analysis shows t</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Sep</publication><modification>2026-05-05T00:44:26.423Z</modification><creation>2020-10-29T08:12:22Z</creation></dates><accession>S-EPMC7527228</accession><cross_references><pubmed>32998889</pubmed><doi>10.1126/sciadv.aaz3849</doi></cross_references></HashMap>